Bay Street News

Hepion Pharmaceuticals Announces Dosing of First HBV Patient in 28-Day Study of CRV431

August 14, 2019
- NASDAQ Companies
  0
ShareTweet
ShareTweet
» View More News for August 14, 2019

Tweets by baystnews

© 2020 BayStNews.com - All Rights Reserved
  • Home
  • TSX News
  • TSX Venture News
  • NASDAQ Companies
  • NYSE Companies
  • Canadian Stock Exchange News
  • Pink Sheets News
  • OTCBB News
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search